August 15th 2023
Patients with diabetes will be able to save money when ordering insulin and commonly prescribed products, such as continuous glucose monitors and pumps.
October 19th 2022
Your daily dose of clinical news from Patient Care Online.
October 18th 2022
Analysis of national health data found that 16.5% of all adult insulin users skipped doses in the past year.
May 3rd 2022
Treatment with intranasal insulin improved executive function and verbal memory, as well as other measures, in participants with and without type 2 diabetes.
February 23rd 2022
t:slim X2 insulin pump users can now program or cancel bolus dosing with the secure t:connect mobile app already on their phones, says Tandem Diabetes Care.
FDA Grants Insulin Lispro-aabc Label Expansion for use in Insulin Pumps
The novel prandial insulin formulation from Eli Lilly is now approved for administration via continuous subcutaneous insulin infusion with an insulin pump.
Hyperglycemia in Hospitalized COVID-19 Patients Linked with Worse Outcomes
COVID-19 patients with hyperglycemia on hospital admission, with and without diabetes, had increased odds of intubation, ICU admission, and mortality, according to research presented at ENDO 2021.
Novel Once-weekly Insulin as Effective as Once-daily in Type 2 Diabetes with Less Hypoglycemia, Weight Gain
ENDO 2021: An investigational once-weekly insulin formulation was found as effective as daily basal insulin injection for glucose control with lower rates of hypoglycemia and less weight gain.
Issues in Insulin Management: 3 Cases of Type 2 Diabetes
Three patients with type 2 diabetes in different stages of life and disease all require insulin management for A1c control.
ADA 2017: Insulins go Head-to-Head
Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017.
Primary Care Docs Prefer Tight Glucose Control in T2D
Stringent control was supported even in patients at high risk for related harm. Reasons found for concern over Rx "deintensification" may surprise you.
Batting Averages and Sex Improvement
Here’s a look at what’s new and interesting on the Web for health care professionals.
Diabetes Control Too Tight for Some Older Adults
Maintaining tight glycemic control in older diabetic adults who are in poor health can do far more harm than good, according to results of a new study.
Opioid Receptors May Curb Hypoglycemia in Diabetes
Activation of opioid receptors with novel approaches may prevent hypoglycemia and lead to safer intensive glycemic control, according to a study reported at the American Diabetes Association 74th Scientific Sessions.
"Diabetes Is Primary": Primary Care Providers Are the Foundation of Diabetes Care
The fact that a "Diabetes Is Primary" session is held in parallel to the ADA scientific sessions is a significant recognition by the American Diabetes Association that primary care providers are the foundation of diabetes care in the United States. Highlights here.
More Insulin Use for Type 2 Diabetes With Analogs
The use of insulin has grown in recent years largely because of the widespread adoption of analogs. Out-of-pocket expenditures per prescription also increased.
Medication Errors in Adults-Case #11: Nonadherence With Insulin
Remembering the role the patient can play in preventing medication errors is important. Here I focus on potential errors resulting from nonadherence with insulin.
Insulin-Related Hypoglycemia: Elderly Most Vulnerable, Study Says
Patients aged 80 years or older were more than twice as likely to visit the ED and nearly 5 times as likely to be hospitalized for insulin-related hypoglycemia than those aged 45 to 64 years.
Medication Errors in Adults: Case #6: Insulin
Confusion about multiple insulin products; nonadherence to the prescribed regimen; the patient’s injection technique . . . here: a look at why errors occur when insulin is prescribed-and how to prevent them.
Fix Fasting (Glucose) First, But What About PPG?
GLP-1 receptor antagonists suppress post-meal glucose excursions and are compatible with basal insulin; the combination addresses both FPG and PPG.
On Site at the ADA: Insulin and Incretins Take Center Stage
Combination therapy that addresses both fasting and post-meal glucose elevation is the next big thing in T2DM management.
2 Clarke Drive Cranbury, NJ 08512